ClinicalTrials.Veeva

Menu

Oral Nutritional Optimization in Total Joint Arthroplasty

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Osteoarthritis

Treatments

Dietary Supplement: Ensure

Study type

Interventional

Funder types

Other

Identifiers

NCT04210284
18-01976

Details and patient eligibility

About

The purpose of this study is to determine the effect on hematological markers of nutritional intervention on nutritionally deficient patients following total joint replacement surgery.

Full description

Numerous pre-operative modifiable variables have been extensively investigated for their effect on outcomes in TJA. These include metabolic diseases such as diabetes mellitus, obesity, and smoking status. However, nutritional status has not been as thoroughly investigated; to date, no prospective randomized control study has assessed the effect of oral nutritional supplementation for malnourished patients. This study will be a novel investigation into the role for routine serum screening for malnutrition as well as oral nutritional supplementation in TJA patients. This study could serve as a stepping stone towards creating a new pathway to highlight at-risk patients and pre-operatively optimizing their outcomes after TJA.

Enrollment

72 estimated patients

Sex

All

Ages

55+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patient are current candidates for elective primary total hip and total knee arthroplasty
  2. Patients ≥55 years of age but ≤ 95
  3. Patients who meet at least one of the following three laboratory criteria for malnutrition:

TSerum Albumin: ≤3.5 mg/dl Pre-Albumin: <15 mg/dl Transferrin: <200 mg/dl

Exclusion criteria

  1. Previous history of septic arthritis
  2. Allergy to oral supplementation
  3. Inability to consume oral supplementation
  4. Protein malabsorption syndromes
  5. Eating disorders
  6. End stage renal and hepatic disease
  7. Revision surgery, non-elective surgery, hemiarthroplasty, and unicompartmental knee arthroplasty

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

72 participants in 2 patient groups

Nutritional supplementation
Experimental group
Description:
Given Ensure Max Protein Nutrition shake 2 weeks before surgery and continued 2 weeks after surgery.
Treatment:
Dietary Supplement: Ensure
No Nutritional supplementation
No Intervention group
Description:
Treatment as usual

Trial contacts and locations

2

Loading...

Central trial contact

Daniel Waren

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems